BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18281780)

  • 1. [Gastric cancer: histological type, histogenesis, and gene abnormalities].
    Tamura G
    Gan To Kagaku Ryoho; 2008 Feb; 35(2):343-9. PubMed ID: 18281780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer.
    Tamura G
    World J Gastroenterol; 2006 Jan; 12(2):192-8. PubMed ID: 16482617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic pathways of two types of gastric cancer.
    Tahara E
    IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microsatellite alterations in differentiated-type adenocarcinomas and precancerous lesions of the stomach with special reference to cellular phenotype.
    Ohmura K; Tamura G; Endoh Y; Sakata K; Takahashi T; Motoyama T
    Hum Pathol; 2000 Sep; 31(9):1031-5. PubMed ID: 11014567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microsatellite alterations and target gene mutations in the early stages of multiple gastric cancer.
    Ogata S; Tamura G; Endoh Y; Sakata K; Ohmura K; Motoyama T
    J Pathol; 2001 Jul; 194(3):334-40. PubMed ID: 11439366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of undifferentiated-type gastric carcinoma.
    Tamura G; Sato K; Akiyama S; Tsuchiya T; Endoh Y; Usuba O; Kimura W; Nishizuka S; Motoyama T
    Lab Invest; 2001 Apr; 81(4):593-8. PubMed ID: 11304579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and epigenetic alterations of tumor suppressor and tumor-related genes in gastric cancer.
    Tamura G
    Histol Histopathol; 2002 Jan; 17(1):323-9. PubMed ID: 11813881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation between histological and molecular mechanisms of carcinogenesis in stomach cancer].
    Rüschoff J; Mehringer S; Beyser K; Dietmaier W; Langner C; Bocker T; Kullmann F
    Verh Dtsch Ges Pathol; 1999; 83():71-8. PubMed ID: 10714197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and epigenetic alterations in multistep carcinogenesis of the stomach.
    Yasui W; Yokozaki H; Fujimoto J; Naka K; Kuniyasu H; Tahara E
    J Gastroenterol; 2000; 35 Suppl 12():111-5. PubMed ID: 10779229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
    Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
    Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathology and molecular biology of gastric cancer.
    Vauhkonen M; Vauhkonen H; Sipponen P
    Best Pract Res Clin Gastroenterol; 2006; 20(4):651-74. PubMed ID: 16997151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetic and molecular aspects of gastric cancer: clinical implications.
    Panani AD
    Cancer Lett; 2008 Aug; 266(2):99-115. PubMed ID: 18381231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms involved in the pathogenesis of gastric carcinoma: interactions between genetic alterations, cellular phenotype and cancer histotype.
    Fiocca R; Luinetti O; Villani L; Mastracci L; Quilici P; Grillo F; Ranzani GN
    Hepatogastroenterology; 2001; 48(42):1523-30. PubMed ID: 11813565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular biology of gastric cancer.
    El-Rifai W; Powell SM
    Semin Radiat Oncol; 2002 Apr; 12(2):128-40. PubMed ID: 11979414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular phenotypes of differentiated-type adenocarcinomas and precancerous lesions of the stomach are dependent on the genetic pathways.
    Endoh Y; Sakata K; Tamura G; Ohmura K; Ajioka Y; Watanabe H; Motoyama T
    J Pathol; 2000 Jul; 191(3):257-63. PubMed ID: 10878546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric cancer with high-level microsatellite instability: target gene mutations, clinicopathologic features, and long-term survival.
    Falchetti M; Saieva C; Lupi R; Masala G; Rizzolo P; Zanna I; Ceccarelli K; Sera F; Mariani-Costantini R; Nesi G; Palli D; Ottini L
    Hum Pathol; 2008 Jun; 39(6):925-32. PubMed ID: 18440592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candidate regions of tumor suppressor gene by loss of heterozygosity analysis on chromosome 8p11.1-q13.3 in gastric cancer.
    Kakinuma N; Kohu K; Sato M; Yamada T; Nakajima M; Akiyama T; Ohwada S; Shibanaka Y
    Cancer Lett; 2004 Sep; 213(1):111-6. PubMed ID: 15312690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 genetic abnormalities and P-glycoprotein expression in stump and primary gastric carcinomas.
    Oliver I; Lacueva J; Barberá V; Caldés T; Teruel A; Costa D; Medrano J; Pérez-Vázquez T; Quesada P; Ferragut J; Calpena R
    Hepatogastroenterology; 2007 Mar; 54(74):377-81. PubMed ID: 17523278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial and stromal genetic instability linked to tumor suppressor genes in ulcerative colitis-associated tumorigenesis.
    Yagishita H; Yoshida T; Ishiguro K; Numata Y; Okayasu I
    Scand J Gastroenterol; 2008; 43(5):559-66. PubMed ID: 18415748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation of tumor-related genes in neoadjuvant-treated gastric cancer: relation to therapy response and clinicopathologic and molecular features.
    Napieralski R; Ott K; Kremer M; Becker K; Boulesteix AL; Lordick F; Siewert JR; Höfler H; Keller G
    Clin Cancer Res; 2007 Sep; 13(17):5095-102. PubMed ID: 17785563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.